BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05633654-completion@plaintrial.com
DTSTAMP:20261027T111309Z
DTSTART;VALUE=DATE:203108
SUMMARY:Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatm
 ent of Physician's Choice in Patients With Triple Negative Breast Cancer W
 ho Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (A
 SCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63) — estimated completion d
 ate
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT05633654
URL:https://plaintrial.com/trial/NCT05633654
END:VEVENT
END:VCALENDAR